Trial Profile
International Multi-center Comparative Double-blind Randomized Clinical Trial of Efficacy and Safety of BCD-055 (JSC BIOCAD, Russia) and Remicade in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Folic acid; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms LIRA
- Sponsors Biocad
- 24 Apr 2019 Status changed from active, no longer recruiting to completed.
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 22 Feb 2018 Status changed from recruiting to active, no longer recruiting.